Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression in a Prospective, Multinational, Multicentre Observational Study

NCT06351670 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT06351670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06351670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression in a Prospective, Multinational, Multicentre Observational Study
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Recruiting
Start date
February 25, 2025
Completion date
July 31, 2027
Enrollment
500 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration